Years increasing dividends3.1
#62 of 10031 reported increase years. Years / 10, capped at 5 points.
Nanalyze Dividend
NVO Novo Nordisk A/S
Nanalyze identified Novo Nordisk as the top name in its 200-stock dividend-growth universe in August 2025.
Q-score estimate30.7#1 of 100 assessed stocks
Dividend yield and international sales contribute the most. Years increasing dividends is the largest constraint. Independent estimate from dated inputs, not a publisher Q-score.
Hypothetical investment
Growth of $10,000
Dividends reinvested · no additional contributions
NVO would be worth$9,7315-year growth · as of Sep 18, 2026
S&P 500 (SPY)$18,763Same $10,000 · same dates
Total gain / loss−$269-2.7% total return
NVOS&P 500 (SPY)
Sep 20, 2021 · $10,000 investedSep 18, 2026
Based on adjusted market prices through the latest available completed session, before personal taxes and trading costs.
Checking the latest completed session…
Market performance
Total return
Price movement plus reinvested distributions, compared with SPY.
-2.7% over 5 years
1 YEAR TOTAL RETURN-26.6%#96 return rank · 100 peers
Price-30.1%
Dividend+3.5%
Net loss; shares not shown.
5 YEARS TOTAL RETURN-2.7%-0.5% / yr annualized#79 return rank · 99 peers
Price-13.2%
Dividend+10.5%
Net loss; shares not shown.
Dividend includes all distributions and reinvestment.
Sep 20, 2021Sep 18, 2026
Total return-2.69%
S&P 500 (SPY)+87.63%
Annualized return-0.55%
Largest drawdown-74.70%
Transparent factor breakdown
Official framework Why the Q-score estimate is 30.7
Each rank compares this stock with the 100 assessed stocks in the Nanalyze collection.
Market capitalization4.5
#16 of 100$169.11 billion. 2 × log10(market cap in USD billions), limited to 0–5 points.
Dividend yield5.0
#1 of 1004.87%. 2 × (yield % − 1.5), limited to −2–5 points.
Payout ratio3.2
#40 of 10042.69%. (90 − payout %) / 15, limited to −2–5 points. Zero or negative payout receives −2 rather than a false coverage reward.
International sales5.0
#1 of 10099.20% source geographic share. At most 25%: −1 point; above 25% through 50%: 2.5; above 50%: 5. A verified upper bound is usable only when entirely within the lowest band.
5-year dividend growth5.0
#1 of 10020.79%. (5-year growth % − 5) / 3, limited to −2–5 points.
10-year dividend growth4.9
#5 of 10013.84%. (10-year growth % − 4) / 2, limited to −2–5 points.
Independent estimate · assessed October 10, 2026. All 100 research stocks use the same rules. Each component is rounded to one decimal before summing; equal totals share a rank. These scores are not Nanalyze’s published Q-scores. Full method
Supplied Quantigence ALL calculator; imported 2026-09-23; effective date unstated. Quantigence Q-Score Calculator - ALL.csv, row 2; source symbol NOVO.CO. Supplied publisher total: 27.6 (separate scale; not used in this ranking).
Inputs are a supplied calculator snapshot, not live values; its effective date is unstated. Geography and payout definitions are retained as supplied.
Issuer-level metrics mapped from NOVO.CO to NVO. Source-listing yield and dividend growth can differ from the US listing due to currency and ADR mechanics.
Market cap is explicitly USD-denominated $169.11bn observed 2026-10-09; overrides the foreign-listing calculator amount to avoid currency ambiguity. Other inputs retain their source definitions and unstated date.